Bioenvision (NASDAQ:BIVN) today announced financial results for the third quarter ended March 31, 2006. Highlights of the quarter include: ?...
Bioenvision (NASDAQ: BIVN) today announced that the Company will host a conference call with the financial community to discuss the third quarter...
Bioenvision, Inc. (Nasdaq:BIVN) announced today that Hugh Griffith, Chief Operating Officer of the Company, is scheduled to present at the Rodman...
Bioenvision, Inc. (Nasdaq: BIVN) announced today that Dr. Christopher B. Wood, Chairman and Chief Executive Officer, is scheduled to present at...
Bioenvision (Nasdaq: BIVN) today announced that an overall response had been achieved in 92% of patients over 60 yrs of age with acute myeloid...
Bioenvision, Inc. (Nasdaq:BIVN) today announced that the Scientific Program Committee of the American Society of Clinical Oncology (ASCO) has...
Bioenvision (NASDAQ: BIVN) today announced that the Company will host a conference call with the financial community to discuss the CHMP positive...
Bioenvision (Nasdaq: BIVN) today announced that the European Medicines Agency has adopted a positive opinion on the marketing authorization...
Please replace the release with the following corrected version due to multiple revisions (a financial table and note were inserted and two bullet...
Bioenvision (NASDAQ NM: BIVN) today announced financial results for the second quarter ended December 31, 2005. Highlights of the quarter...
Bioenvision (NASDAQ NM: BIVN) today announced that the Company will host a conference call with the financial community to discuss the second...
NEW YORK, Jan. 20 /PRNewswire/ -- The American Stock Exchange(R) (Amex) (R) will launch trading in options on Monday, January 23, 2006 on the...
Bioenvision, Inc. (Nasdaq: BIVN) announced today that Dr. Christopher B. Wood, Chairman and Chief Executive Officer of the Company, will present...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.